HUM vs SGMO
Humana Inc (HUM) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the HUM and SGMO stock pages for the full models.
Not investment advice.